Novasoy

MFDS recognition no.	2009-26
Approval route	Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)	25.0–25.0 mg/day
Approval holder	(주)뉴트리션웨이브

Approved wording (Korean original)

“뼈 건강에 도움을 줄 수 있습니다.” (기타기능 II)

Precautions (Korean original)

1) 섭취시 대상자는 폐경기 여성임. 2) 임산부와 수유 여성은 섭취를 삼가야 함. 3) 영유아, 어린이는 섭취를 삼가야 함. 4) 대두 이소플라본에 민감한 사람은 섭취를 삼가야 함. 5) 갑상선, 유방암, 자궁내막암, 방광암 환자 등은 섭취를 삼가야 함.

the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.